DAVID R WILLIAMS

Allopathic & Osteopathic Physicians|Family Medicine BELTON, MO NPI 1275528895

General Payments — all program years on this page

$5,661.03

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 375
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $389.32 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $389.3221

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $657.8053
2019 $881.3369
2020 $582.0542
2021 $1,219.5278
2022 $956.6857
2023 $974.3355
2024 $389.3221

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096569358 Novo Nordisk Inc $19.02 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097252362 Novo Nordisk Inc $14.97 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097283094 Novo Nordisk Inc $18.51 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097520192 Novo Nordisk Inc $19.42 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097663864 Novo Nordisk Inc $19.30 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104204787 AstraZeneca Pharmaceuticals LP $14.49 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105519207 AstraZeneca Pharmaceuticals LP $13.91 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106340387 ABBVIE INC. $23.19 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106340389 ABBVIE INC. $16.28 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106340391 ABBVIE INC. $29.90 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119004751 Otsuka America Pharmaceutical, Inc. $15.03 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124944302 Abbott Laboratories $24.44 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124944306 Abbott Laboratories $22.40 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131906215 PFIZER INC. $14.94 01/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131915358 PFIZER INC. $18.11 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131915606 PFIZER INC. $18.51 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131920463 PFIZER INC. $15.61 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136127997 Lilly USA, LLC $19.69 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136136178 Lilly USA, LLC $19.17 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150123101 SHIELD THERAPEUTICS INC $18.30 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153748019 Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.13 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.